Clinical Trial Update: Safety and Efficacy Study of AGN-214868 in Patients With Idiopathic Overactive Bladder and Urinary Incontinence [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the safety and efficacy of AGN-214868 in adults with idiopathic overactive bladder and urinary incontinence completed. Results were pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder
• Urinary Incontinence

Drugs mentioned

• AGN-214868

Snippet

Sponsor: Allergan | Conditions: Urinary Bladder, Overactive | Phase 2 | Status: COMPLETED | Results posted: 2014-03-19